Pub Date : 2025-10-14Epub Date: 2024-09-30DOI: 10.4081/monaldi.2024.2991
Amit Sharma, Deepak Rathi, Prerna Jain, Devika Tayal
Chronic obstructive pulmonary disease (COPD) presents as a multifaceted clinical landscape with various hematological manifestations. Among these, polycythemia and anemia pose distinct challenges. While the prevalence of polycythemia has decreased in recent years, anemia remains a prevalent concern, impacting patient outcomes. This study investigated the incidence and clinical characteristics of polycythemia in COPD patients, focusing on a diverse cohort in India. Methodological approaches included comprehensive evaluations of clinical parameters, pulmonary function, and hematological profiles. Results revealed significant variations in COPD severity, pulmonary function, and respiratory symptoms among patients with different hemoglobin levels. The findings shed light on the complex interplay between hematological variations and clinical manifestations in COPD, providing valuable insights for disease management strategies.
{"title":"Hematological and clinical profiling of chronic obstructive pulmonary disease: a comprehensive study.","authors":"Amit Sharma, Deepak Rathi, Prerna Jain, Devika Tayal","doi":"10.4081/monaldi.2024.2991","DOIUrl":"10.4081/monaldi.2024.2991","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) presents as a multifaceted clinical landscape with various hematological manifestations. Among these, polycythemia and anemia pose distinct challenges. While the prevalence of polycythemia has decreased in recent years, anemia remains a prevalent concern, impacting patient outcomes. This study investigated the incidence and clinical characteristics of polycythemia in COPD patients, focusing on a diverse cohort in India. Methodological approaches included comprehensive evaluations of clinical parameters, pulmonary function, and hematological profiles. Results revealed significant variations in COPD severity, pulmonary function, and respiratory symptoms among patients with different hemoglobin levels. The findings shed light on the complex interplay between hematological variations and clinical manifestations in COPD, providing valuable insights for disease management strategies.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-09-10DOI: 10.4081/monaldi.2024.2898
Davide Tarello, Francesca Giogà, Andrea Lauterio, Chiara Becchetti, Giovanni Perricone, Giorgio Santi, Monica Ragazzi, Gianpaola Monti, Marta Lazzeri
Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. Due to the recipients' generally poor pre-operative clinical conditions and extensive surgery, post-LT respiratory disorders are very common and significantly contribute to related morbidity and mortality. We report the case of a 49-year-old patient with ACLF grade 3 who has been taken care of by the Respiratory Physiotherapy Team since hospital admission. After the extubation, the patient was supported with non-invasive ventilation and mechanical in-exsufflation; meanwhile, early resistance and functional training were started. No adverse events occurred during physiotherapy sessions, and the patient returned home without respiratory support. Respiratory and physical therapy in the intensive care unit after LT were safe and feasible interventions for this patient. Given the high incidence of postoperative pulmonary complications and the high rehabilitation needs, we suggest that physiotherapy should be provided for ACLF recipients.
{"title":"Respiratory and physical therapy in the intensive care unit after liver transplantation for acute-on-chronic liver failure: a case report.","authors":"Davide Tarello, Francesca Giogà, Andrea Lauterio, Chiara Becchetti, Giovanni Perricone, Giorgio Santi, Monica Ragazzi, Gianpaola Monti, Marta Lazzeri","doi":"10.4081/monaldi.2024.2898","DOIUrl":"10.4081/monaldi.2024.2898","url":null,"abstract":"<p><p>Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. Due to the recipients' generally poor pre-operative clinical conditions and extensive surgery, post-LT respiratory disorders are very common and significantly contribute to related morbidity and mortality. We report the case of a 49-year-old patient with ACLF grade 3 who has been taken care of by the Respiratory Physiotherapy Team since hospital admission. After the extubation, the patient was supported with non-invasive ventilation and mechanical in-exsufflation; meanwhile, early resistance and functional training were started. No adverse events occurred during physiotherapy sessions, and the patient returned home without respiratory support. Respiratory and physical therapy in the intensive care unit after LT were safe and feasible interventions for this patient. Given the high incidence of postoperative pulmonary complications and the high rehabilitation needs, we suggest that physiotherapy should be provided for ACLF recipients.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-08-29DOI: 10.4081/monaldi.2024.3039
Paolo Toritto, Elena Cescutti, Igor Vendramin, Michela Puppato, Massimo Imazio, Stefano De Carli, Olga Vriz
The authors present a case report of a 68-year-old man evaluated at the emergency department for repeated syncope, asthenia, and general malaise, suggesting heart failure in a patient with several comorbidities. At presentation, the patient was afebrile, but he had reported a low-grade fever in the previous 6 months. At first glance, transthoracic echocardiography was not clear, while transesophageal echocardiography revealed an echo-free image at the level of the non-coronary sinus of the aortic root, suggestive of a pseudoaneurysm communicating with the right atrium with continuous systo-diastolic flow, compatible with the aorto-cavitary fistula between the aortic root and the RA. Echocardiographic findings were confirmed by cardiac computed tomography. The case was discussed with the heart team and was considered suitable for surgery, but the patient suddenly died just before surgery due to impairment and friability.
作者报告了一例 68 岁男性患者的病例,该患者因反复晕厥、气喘和全身乏力而到急诊科就诊。就诊时,患者无发热,但此前六个月曾报告过低烧。乍一看,经胸超声心动图并不清晰,而经食道超声心动图显示主动脉根部非冠状动脉窦水平有无回声图像,提示假性动脉瘤,与右心房相通,有持续的收缩-舒张期血流,与主动脉根部和 RA 之间的主动脉空腔瘘相符。心脏计算机断层扫描证实了超声心动图结果。该病例经与心脏团队讨论后被认为适合手术,但患者在手术前因功能受损和易碎而突然死亡。
{"title":"Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report.","authors":"Paolo Toritto, Elena Cescutti, Igor Vendramin, Michela Puppato, Massimo Imazio, Stefano De Carli, Olga Vriz","doi":"10.4081/monaldi.2024.3039","DOIUrl":"10.4081/monaldi.2024.3039","url":null,"abstract":"<p><p>The authors present a case report of a 68-year-old man evaluated at the emergency department for repeated syncope, asthenia, and general malaise, suggesting heart failure in a patient with several comorbidities. At presentation, the patient was afebrile, but he had reported a low-grade fever in the previous 6 months. At first glance, transthoracic echocardiography was not clear, while transesophageal echocardiography revealed an echo-free image at the level of the non-coronary sinus of the aortic root, suggestive of a pseudoaneurysm communicating with the right atrium with continuous systo-diastolic flow, compatible with the aorto-cavitary fistula between the aortic root and the RA. Echocardiographic findings were confirmed by cardiac computed tomography. The case was discussed with the heart team and was considered suitable for surgery, but the patient suddenly died just before surgery due to impairment and friability.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-07-25DOI: 10.4081/monaldi.2024.2909
Unnati Desai, Saby Ak, Ketaki Utpat, Jyoti Bacche
The World Health Organization endorsed the cartridge-based nucleic acid amplification test Xpert MTB/RIF (GXP) for the diagnosis of tuberculosis (TB). Studies about GXP efficiency in extrapulmonary TB (EPTB) are scarce. Hence, we decided to study the role of GXP in EPTB. This prospective observational study, conducted in the pulmonary medicine department of a tertiary care hospital after ethics committee permission, recruited 200 EPTB patients. The diagnosis of TB was achieved with the help of clinico-radiological correlation with microbiological test positivity. Acid-fast bacilli (AFB) culture was treated as the comparative gold standard. Patients who had no or incomplete data were excluded from the study. Data were analyzed to calculate the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of TB and the detection of rifampicin resistance. The majority of cases were women (126 patients: 63%). The mean age was 23.71 years. On GXP, 130 (65%) had detected Mycobacterium tuberculosis, and 70 (35%) did not. Adding AFB culture data, 168 (81.5%) showed microbiological evidence of TB, and 32 (18.5%) were negative. On the drug susceptibility test, 131 cases were rifampicin-sensitive, 32 were rifampicin-resistant TB, and in 5 cases, data were unavailable. The most common extrapulmonary site of involvement was the lymph node, with 94 patients (47%). The most common lymph node involved was the cervical lymph node, with 70 patients (74.5%). The sensitivity, specificity, positive predictive value, and negative predictive value of GXP in EPTB collectively were 76.68%, 86.48%, 96%, and 45.7%, respectively. GXP is useful for the rapid detection of EPTB and the identification of rifampicin resistance, especially in a high-prevalence country like India.
{"title":"Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis.","authors":"Unnati Desai, Saby Ak, Ketaki Utpat, Jyoti Bacche","doi":"10.4081/monaldi.2024.2909","DOIUrl":"10.4081/monaldi.2024.2909","url":null,"abstract":"<p><p>The World Health Organization endorsed the cartridge-based nucleic acid amplification test Xpert MTB/RIF (GXP) for the diagnosis of tuberculosis (TB). Studies about GXP efficiency in extrapulmonary TB (EPTB) are scarce. Hence, we decided to study the role of GXP in EPTB. This prospective observational study, conducted in the pulmonary medicine department of a tertiary care hospital after ethics committee permission, recruited 200 EPTB patients. The diagnosis of TB was achieved with the help of clinico-radiological correlation with microbiological test positivity. Acid-fast bacilli (AFB) culture was treated as the comparative gold standard. Patients who had no or incomplete data were excluded from the study. Data were analyzed to calculate the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of TB and the detection of rifampicin resistance. The majority of cases were women (126 patients: 63%). The mean age was 23.71 years. On GXP, 130 (65%) had detected Mycobacterium tuberculosis, and 70 (35%) did not. Adding AFB culture data, 168 (81.5%) showed microbiological evidence of TB, and 32 (18.5%) were negative. On the drug susceptibility test, 131 cases were rifampicin-sensitive, 32 were rifampicin-resistant TB, and in 5 cases, data were unavailable. The most common extrapulmonary site of involvement was the lymph node, with 94 patients (47%). The most common lymph node involved was the cervical lymph node, with 70 patients (74.5%). The sensitivity, specificity, positive predictive value, and negative predictive value of GXP in EPTB collectively were 76.68%, 86.48%, 96%, and 45.7%, respectively. GXP is useful for the rapid detection of EPTB and the identification of rifampicin resistance, especially in a high-prevalence country like India.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-07-25DOI: 10.4081/monaldi.2024.3029
Aladdin Bashir, Zaheer Tahir, Mahmood Ahmad, Kyriacos Mouyis, Ali Zuhair Kirresh, Sameh Atta, Clinton Lloyd, Malcolm Dalrymple-Hay
Tricuspid regurgitation (TR) is the most common pathology of the tricuspid valve. Moderate to severe TR is associated with morbidity and adverse outcomes. The concept that TR resolves on its own if the underlying disease is successfully treated has proven to be false. Only a few patients with significant TR are deemed suitable for surgery. Given the late presentation of patients with high perioperative risks and substantial perioperative mortality, the development of transcatheter therapies and the experience gained with transcatheter aortic valve implantation operations have turned attention towards treating this challenging group of patients. In this article, we review the treatment options and highlight the role of transcatheter valve therapies in patients with severe TR.
{"title":"A decade's summary of transcatheter tricuspid valve repair.","authors":"Aladdin Bashir, Zaheer Tahir, Mahmood Ahmad, Kyriacos Mouyis, Ali Zuhair Kirresh, Sameh Atta, Clinton Lloyd, Malcolm Dalrymple-Hay","doi":"10.4081/monaldi.2024.3029","DOIUrl":"10.4081/monaldi.2024.3029","url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) is the most common pathology of the tricuspid valve. Moderate to severe TR is associated with morbidity and adverse outcomes. The concept that TR resolves on its own if the underlying disease is successfully treated has proven to be false. Only a few patients with significant TR are deemed suitable for surgery. Given the late presentation of patients with high perioperative risks and substantial perioperative mortality, the development of transcatheter therapies and the experience gained with transcatheter aortic valve implantation operations have turned attention towards treating this challenging group of patients. In this article, we review the treatment options and highlight the role of transcatheter valve therapies in patients with severe TR.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-08-29DOI: 10.4081/monaldi.2024.3013
Maurizio Santomauro, Mario Petretta, Carla Riganti, Mario Alberto Santomauro, Mariarosaria De Luca, Andrea Santomauro, Antonio Cittadini
Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies published between January 2010 and December 2019 assessing IAS due to cardiac oversensing by the selection process (PRISMA) and identified 17 eligible articles. A total of 15 studies were observational, and 2 were retrospective. For the meta-analysis, the final population included 6111 patients: 3356 without the SMART-pass (SP) filter (group 1) and 2755 with the SP filter (group 2). A total of 1614 shocks (appropriate shocks plus IAS) were registered (1245 in group 1 and 369 in group 2). The random effects meta-analysis estimated an overall IAS rate of 7.78% (95% confidence interval: 4.93-10.64) with substantial variability between studies (I2=96.05%, p<0.001). The IAS rate was 10.75% (95% confidence interval: 8.49-13.02) for group 1 and 3.61% (95% confidence interval: 1.36-5.86) for group 2 (p<0.001). Third-generation S-ICD technology with SP filters reduced the risk of cardiac signal-related IAS.
{"title":"Reduction of inappropriate shock rate through signal filtering (smart-pass) in patients with implantable subcutaneous cardioverter-defibrillator: a systematic review and meta-analysis.","authors":"Maurizio Santomauro, Mario Petretta, Carla Riganti, Mario Alberto Santomauro, Mariarosaria De Luca, Andrea Santomauro, Antonio Cittadini","doi":"10.4081/monaldi.2024.3013","DOIUrl":"10.4081/monaldi.2024.3013","url":null,"abstract":"<p><p>Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies published between January 2010 and December 2019 assessing IAS due to cardiac oversensing by the selection process (PRISMA) and identified 17 eligible articles. A total of 15 studies were observational, and 2 were retrospective. For the meta-analysis, the final population included 6111 patients: 3356 without the SMART-pass (SP) filter (group 1) and 2755 with the SP filter (group 2). A total of 1614 shocks (appropriate shocks plus IAS) were registered (1245 in group 1 and 369 in group 2). The random effects meta-analysis estimated an overall IAS rate of 7.78% (95% confidence interval: 4.93-10.64) with substantial variability between studies (I2=96.05%, p<0.001). The IAS rate was 10.75% (95% confidence interval: 8.49-13.02) for group 1 and 3.61% (95% confidence interval: 1.36-5.86) for group 2 (p<0.001). Third-generation S-ICD technology with SP filters reduced the risk of cardiac signal-related IAS.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shock management in intensive care unit (ICU) patients requires accurate assessment of fluid responsiveness to optimize outcomes. Dynamic indices, such as passive leg raising (PLR), are often underutilized due to invasive or complex techniques. Our aim was to evaluate change in end-tidal carbon dioxide (EtCO₂) during PLR as a non-invasive dynamic index of fluid responsiveness in mechanically ventilated ICU patients with shock. This was a prospective, observational cohort study conducted in a respiratory ICU at a tertiary care center in New Delhi, India. The study recruited adult patients on mechanical ventilation with shock between November 2022 and April 2024. After screening 340 ICU admissions during the recruitment period for inclusions and exclusions, a total of 90 adult patients on mechanical ventilation with shock were enrolled in the study. Measurements of EtCO₂ via mainstream capnography and cardiac output (CO) with transthoracic echocardiography (TTE) were done pre- and post-PLR. Fluid responsiveness was defined as a ≥10% increase in CO measured via TTE following PLR. Simultaneously, EtCO₂ was measured, with a ≥5% increase considered predictive of fluid responsiveness. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) were calculated for EtCO₂. The study found a sensitivity of 86.8% and specificity of 88.5% for a ≥5% increase in EtCO₂, with an AUROC of 0.951, indicating high diagnostic accuracy. A significant correlation was observed between EtCO₂ changes and fluid responsiveness, validating EtCO₂ as a reliable predictor comparable to TTE. To conclude, EtCO₂ monitoring during PLR is a practical, non-invasive tool for assessing fluid responsiveness in ICU patients with shock. This method is suitable for bedside application, particularly in resource-limited settings, and supports informed fluid management decisions. Further multicenter studies are recommended to confirm its broader applicability.
{"title":"Evaluation of end-tidal carbon dioxide as a marker of fluid responsiveness in mechanically ventilated patients with shock: a prospective study in a tertiary care center in India.","authors":"Ganesh Narwade, Shibdas Chakrabarti, Rajnish Kaushik, Rohit Kumar, Neeraj Gupta, Nitesh Gupta, Pranav Ish, Manu Madan, Mahendran Aj, Tanmaya Talukdar","doi":"10.4081/monaldi.2025.3387","DOIUrl":"https://doi.org/10.4081/monaldi.2025.3387","url":null,"abstract":"<p><p>Shock management in intensive care unit (ICU) patients requires accurate assessment of fluid responsiveness to optimize outcomes. Dynamic indices, such as passive leg raising (PLR), are often underutilized due to invasive or complex techniques. Our aim was to evaluate change in end-tidal carbon dioxide (EtCO₂) during PLR as a non-invasive dynamic index of fluid responsiveness in mechanically ventilated ICU patients with shock. This was a prospective, observational cohort study conducted in a respiratory ICU at a tertiary care center in New Delhi, India. The study recruited adult patients on mechanical ventilation with shock between November 2022 and April 2024. After screening 340 ICU admissions during the recruitment period for inclusions and exclusions, a total of 90 adult patients on mechanical ventilation with shock were enrolled in the study. Measurements of EtCO₂ via mainstream capnography and cardiac output (CO) with transthoracic echocardiography (TTE) were done pre- and post-PLR. Fluid responsiveness was defined as a ≥10% increase in CO measured via TTE following PLR. Simultaneously, EtCO₂ was measured, with a ≥5% increase considered predictive of fluid responsiveness. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) were calculated for EtCO₂. The study found a sensitivity of 86.8% and specificity of 88.5% for a ≥5% increase in EtCO₂, with an AUROC of 0.951, indicating high diagnostic accuracy. A significant correlation was observed between EtCO₂ changes and fluid responsiveness, validating EtCO₂ as a reliable predictor comparable to TTE. To conclude, EtCO₂ monitoring during PLR is a practical, non-invasive tool for assessing fluid responsiveness in ICU patients with shock. This method is suitable for bedside application, particularly in resource-limited settings, and supports informed fluid management decisions. Further multicenter studies are recommended to confirm its broader applicability.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-08-30DOI: 10.4081/monaldi.2024.2981
Sarkar Malay, Irappa V Madabhavi, Anurag Tripathi
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense RNA virus. The SARS-CoV-2 virus is evolving continuously, and many variants have been detected over the last few years. SARS-CoV-2, as an RNA virus, is more prone to mutating. The continuous evolution of the SARS-CoV-2 virus is due to genetic mutation and recombination during the genomic replication process. Recombination is a naturally occurring phenomenon in which two distinct viral lineages simultaneously infect the same cellular entity in an individual. The evolution rate depends on the rate of mutation. The rate of mutation is variable among the RNA viruses, with the SARS-CoV-2 virus exhibiting a lower rate of mutation than other RNA viruses. The novel 3'-to-5' exoribonuclease proofreading machinery is responsible for a lower rate of mutation. Infections due to SARS-CoV-2, influenza, and respiratory syncytial virus have been reported from around the world during the same period of fall and winter, resulting in a "tripledemic". The JN.1 variant, which evolved from the predecessor, the Omicron variant BA.2.86, is currently the most dominant globally. The impact of the JN.1 variant on transmissibility, disease severity, immune evasion, and diagnostic and therapeutic escape will be discussed.
{"title":"SARS-CoV-2 JN.1 variant: a short review.","authors":"Sarkar Malay, Irappa V Madabhavi, Anurag Tripathi","doi":"10.4081/monaldi.2024.2981","DOIUrl":"10.4081/monaldi.2024.2981","url":null,"abstract":"<p><p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense RNA virus. The SARS-CoV-2 virus is evolving continuously, and many variants have been detected over the last few years. SARS-CoV-2, as an RNA virus, is more prone to mutating. The continuous evolution of the SARS-CoV-2 virus is due to genetic mutation and recombination during the genomic replication process. Recombination is a naturally occurring phenomenon in which two distinct viral lineages simultaneously infect the same cellular entity in an individual. The evolution rate depends on the rate of mutation. The rate of mutation is variable among the RNA viruses, with the SARS-CoV-2 virus exhibiting a lower rate of mutation than other RNA viruses. The novel 3'-to-5' exoribonuclease proofreading machinery is responsible for a lower rate of mutation. Infections due to SARS-CoV-2, influenza, and respiratory syncytial virus have been reported from around the world during the same period of fall and winter, resulting in a \"tripledemic\". The JN.1 variant, which evolved from the predecessor, the Omicron variant BA.2.86, is currently the most dominant globally. The impact of the JN.1 variant on transmissibility, disease severity, immune evasion, and diagnostic and therapeutic escape will be discussed.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-14Epub Date: 2024-09-12DOI: 10.4081/monaldi.2024.2986
Andrea Giovanni Parato, Simone D'Agostino, Simona Pelliccioni, Maria Virginia Boni, Andrea Angelini, Francesco Sbaraglia, Vito Maurizio Parato
Non-A non-B aortic dissection is considered a rare nosological entity, included in the Stanford classification, representing a small percentage of the total aortic dissections that occur annually. Regarding this form, the literature reports a more complicated disease course compared to other types of dissection. We describe the case of a 76-year-old patient who accessed the triage section of an emergency department for a polytrauma picture and, after surgical treatment of a leg fracture, received a diagnosis of non-A non-B aortic dissection, "localized" to the arch and incidentally detected. The angio-computed tomography (CT) showed that the only intimal tear was located in the central portion of the aortic arch, with no exit tear. No signs of malperfusion or clinical symptoms related to the aortic finding were evident. The Aortic Team decided on a conservative approach, whereby the patient was started on medical therapy to control blood pressure in a monitored bed of a semi-intensive care unit. The persistent asymptomatic state, a condition of hemodynamic stability, and an unchanged angio-CT picture enabled discharge on day 7 and the assignment to a close follow-up.
非 A 非 B 型主动脉夹层被认为是一种罕见的命名实体,已被纳入斯坦福分类法,在每年发生的主动脉夹层总数中只占很小的比例。与其他类型的主动脉夹层相比,文献报道这种主动脉夹层的病程更为复杂。我们描述了一例 76 岁患者的病例,他因多发性创伤就诊于急诊科分诊区,在接受腿部骨折手术治疗后,被诊断为非 A 非 B 主动脉夹层,"局部 "位于弓部,是偶然发现的。血管计算机断层扫描(CT)显示,唯一的内膜撕裂位于主动脉弓的中央部分,没有出口撕裂。没有明显的灌注不良迹象,也没有与主动脉发现相关的临床症状。主动脉小组决定采取保守疗法,在半重症监护病房的监护床上开始对患者进行药物治疗以控制血压。由于患者持续无症状、血液动力学状况稳定、血管 CT 图像无变化,因此患者在第 7 天就可以出院,并接受密切随访。
{"title":"An incidental finding of localized aortic arch dissection in a polytraumatized patient. A case report and state of the art of <i>non-A non-B</i> aortic dissection.","authors":"Andrea Giovanni Parato, Simone D'Agostino, Simona Pelliccioni, Maria Virginia Boni, Andrea Angelini, Francesco Sbaraglia, Vito Maurizio Parato","doi":"10.4081/monaldi.2024.2986","DOIUrl":"10.4081/monaldi.2024.2986","url":null,"abstract":"<p><p>Non-A non-B aortic dissection is considered a rare nosological entity, included in the Stanford classification, representing a small percentage of the total aortic dissections that occur annually. Regarding this form, the literature reports a more complicated disease course compared to other types of dissection. We describe the case of a 76-year-old patient who accessed the triage section of an emergency department for a polytrauma picture and, after surgical treatment of a leg fracture, received a diagnosis of non-A non-B aortic dissection, \"localized\" to the arch and incidentally detected. The angio-computed tomography (CT) showed that the only intimal tear was located in the central portion of the aortic arch, with no exit tear. No signs of malperfusion or clinical symptoms related to the aortic finding were evident. The Aortic Team decided on a conservative approach, whereby the patient was started on medical therapy to control blood pressure in a monitored bed of a semi-intensive care unit. The persistent asymptomatic state, a condition of hemodynamic stability, and an unchanged angio-CT picture enabled discharge on day 7 and the assignment to a close follow-up.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chronic obstructive pulmonary disease (COPD) is characterized by permanent airflow obstruction due to abnormalities of the airways and alveoli. This study investigated the potential role of Aspergillus species in acute exacerbations of COPD (AE-COPD) and evaluated the diagnostic utility of serum Aspergillus galactomannan antigen. This cross-sectional study, carried out at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022, involved COPD patients aged ≥40 years. Serum galactomannan and serum Aspergillus-specific antibodies were analyzed, along with the collection of demographic details, symptoms, and comorbidities. Statistical analyses, including univariate analysis and receiver operating characteristic (ROC) curve analysis, were performed. Among the 61 recruited COPD patients, 24.5% showed serum galactomannan positivity. Significant associations were found between galactomannan positivity, hemoptysis, and previous tuberculosis. ROC analysis revealed modest diagnostic accuracy (area under the ROC=0.6027) with a sensitivity of 44.4% and a specificity of 83.7% at a cut-off of 0.5. Univariate analysis did not show any potential links between diabetes, hypertension, previous exacerbations, and severe Global Initiative for Chronic Obstructive Lung Disease stages with a risk of exacerbation. Serum galactomannan antigen showed limited sensitivity, and its routine testing may not be justified for predicting exacerbation risk. Further studies are warranted to validate these findings and explore other diagnostic methods using bronchoalveolar lavage galactomannan antigen in AE-COPD.
慢性阻塞性肺疾病(COPD)的特点是由于气道和肺泡异常导致永久性气流阻塞。本研究调查了曲霉菌在慢性阻塞性肺病急性加重(AECOPD)中的潜在作用,并评估了血清曲霉菌半乳甘露聚糖抗原的诊断效用。这项横断面研究于 2021 年 1 月至 2022 年 6 月在贾瓦哈拉尔研究生医学教育与研究院(Jawaharlal Institute of Postgraduate Medical Education and Research)进行,涉及年龄≥40 岁的慢性阻塞性肺病患者。研究分析了血清半乳甘露聚糖和血清曲霉菌特异性抗体,并收集了人口统计学细节、症状和合并症。统计分析包括单变量分析和接收器操作特征曲线(ROC)分析。在招募的 61 名慢性阻塞性肺病患者中,24.5% 的患者血清半乳甘露聚糖呈阳性。半乳甘露聚糖阳性、咯血和既往肺结核之间存在显著关联。ROC分析显示诊断准确性不高(ROC下面积=0.6027),以0.5为临界值,灵敏度为44.4%,特异度为83.7%。单变量分析未显示糖尿病、高血压、既往病情恶化和重度金色阶段与病情恶化风险之间存在任何潜在联系。血清半乳甘露聚糖抗原的灵敏度有限,常规检测可能不足以预测病情恶化的风险。有必要开展进一步的研究来验证这些发现,并探索在 AECOPD 中使用支气管肺泡灌洗液半乳甘露聚糖抗原的其他诊断方法。
{"title":"Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study.","authors":"Jayabharathi Palanivel, Madhusmita Mohanty Mohapatra, Manju Rajaram, Debasis Gochhait, Sunitha Vellathussery Chakkalakkoombil, Rakesh Singh","doi":"10.4081/monaldi.2024.3041","DOIUrl":"10.4081/monaldi.2024.3041","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is characterized by permanent airflow obstruction due to abnormalities of the airways and alveoli. This study investigated the potential role of Aspergillus species in acute exacerbations of COPD (AE-COPD) and evaluated the diagnostic utility of serum Aspergillus galactomannan antigen. This cross-sectional study, carried out at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022, involved COPD patients aged ≥40 years. Serum galactomannan and serum Aspergillus-specific antibodies were analyzed, along with the collection of demographic details, symptoms, and comorbidities. Statistical analyses, including univariate analysis and receiver operating characteristic (ROC) curve analysis, were performed. Among the 61 recruited COPD patients, 24.5% showed serum galactomannan positivity. Significant associations were found between galactomannan positivity, hemoptysis, and previous tuberculosis. ROC analysis revealed modest diagnostic accuracy (area under the ROC=0.6027) with a sensitivity of 44.4% and a specificity of 83.7% at a cut-off of 0.5. Univariate analysis did not show any potential links between diabetes, hypertension, previous exacerbations, and severe Global Initiative for Chronic Obstructive Lung Disease stages with a risk of exacerbation. Serum galactomannan antigen showed limited sensitivity, and its routine testing may not be justified for predicting exacerbation risk. Further studies are warranted to validate these findings and explore other diagnostic methods using bronchoalveolar lavage galactomannan antigen in AE-COPD.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}